Invasive infection of the gastrointestinal tract by Leishmania in patients with AIDS

Infectious Diseases in Clinical Practice

Volumn 6, Issue 3, 1997, Pages 153-158

  De Górgolas, Miguel ^a   Bello, Elena ^a   Blanco, Antonio ^a   Renedo, Guadalupe ^a   Fernández Guerrero, Manuel L ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Div de Enfermedades Infecciosas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; HUMAN; LEISHMANIA; LEISHMANIASIS; MALE; SHORT SURVEY;

EID: 0031010457     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199703000-00004     Document Type: Short Survey

References (58)

1. Górgolas M, Miles MA. Visceral leishmaniasis and AIDS. Nature 1994;372:734.
2. Mengesha B, Auhoy M. Kala-azar among labour immigrants in Metema-Humera region of Ethiopia. Trop Geogr Med 1978;30.199-206.
3. Maru M. Clinical and laboratory features and treatment of visceral leishmaniasis in hospitalized patients in north-western Ethiopia. Am J Trop Med Hyg 1979;28:15-8
4. Hashemi-Nasab A, Zadeh-Shirazi H Visceral leishmaniasis (kala-azar) in Fars province. Iran: study of 130 cases. J Trop Med Hyg 1980;83.119-22.
5. Van Peenen PFD, Reid TP. Leishmaniasis in the Sudan Republic, 6. Clinical and laboratory aspects of kala-azar in hospitalized patients from Upper Nile Province. Am J Trop Med Hyg 1962;11:723-30
6. Manson-Bahr PEC, Heisch RB. Studies in leishmaniasis in East Africa. III Clinical features and treatment. Trans R Soc Trop Med Hyg 1956;50 465-71.
7. Laguna F, García-Samaniego J, Soriano V, et al Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis 1994;19:48-53.
8. Chadli A, Philippe E. La leishmaniose viscerale et le systeme reticulo-histiocytaiere. Arch Inst Pasteur Tunis 1961;38.9-31.
9. Perry HM. Some observations on the occurrence of Leishmania in the intestinal tissues in Indian kala-azar, on the pathological changes occasioned by their presence, and on their possible significance in this situation. J R Army Med Corps 1922;39.323-9.
10. Muigai R, Gatei DG, Shaunak S, Wozniak A, Bryceson ADM. Jejunal function and pathology in visceral leishmaniasis. Lancet 1983;2:476-9.
11. Challacombe DN, Wheeler EE, Phillips MJ, Eden OB. Leishman-Donovan bodies in the duodenal mucosa of a child with kala-azar Br Med J 1983;286:789.
12. Lennox WJ, Smari ME, Little PB Canine leishmaniasis in Canada Can Vet Pathol 1972;13:188-90.
13. Keenan CM, Hendricks LD, Lightner L, Johnson AJ. Visceral leishmaniasis in german shepherd dog. II. Pathology. Vet Pathol 1984;21:80-6.
14. Meleney HE. The histopathology of kala-azar in the hamster, monkey, and man. Am J Pathol 1925;1:147-68.
15. Gonzáez JL, Insa F, Novoa C, Pizarro M. Intestinal amyloidosis in hamsters with visceral leishmaniasis. Br J Exp Pathol 1986;67:353-60.
16. Andrade Z, Andrade S. Alguns novos aspectos da patologia do Calazar. Rev Inst Med Trop Sao Paulo 1966;8: 259-66.
17. Benhassine ML, Mokrani T, Benyahia B, Bendissari K, Keddari M, Khati B. Apport de la biopsie duodenale dans le diagnostic du kala-azar Arch Inst Pasteur Alger 1986; 55:125-10.
18. Daneshbod K. Visceral leishmaniasis (kala-azar) in Iran: a pathologic and electron microscopic study Am J Clin Pathol 1972;57:156-66.
19. Fernändez Guerrero ML, Aguado JM, Buzón L, et al. Visceral leishmaniasis in immunocompromised hosts. AmJ Med 1987;83.1098-1102.
20. Montalbán C, Martínez R, Calleja JL, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989;11:655-60.
21. Montalbán C, Calleja JL, Erice A, et al. Visceral leishma-niasis in patients infected with human immunodeficiency virus J Infect 1990;21:261-70.
22. Medrano FJ, Hernández-Quero J, Jiménez E, et al. Visceral leishmaniasis in HIV-1 infected individuals: a common opportunistic infection in Spain?AIDS 1992;6:1499-1503.
23. Perez-Molina JA, López-Velez R, Fortun J, Quereda C, Antela A, Guerrero A. Leishmaniasis and HIV coinfection. In Proceedings and abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy; 1995: San Francisco (CA). Washington (DC): American Society for Microbiology. 1995.212.
24. Gramiccia M, Gradoni L, Troiani M. HIV-leishmania coinfections in Italy. Isoenzyme characterization of Leishmania causing visceral leishmaniasis in HIV patients Trans R Soc Trop Med Hyg 1992,86.161-3.
25. Marty P, Fuzibert JG, Pratlong F, et al. Leishmaniose viscérale causée par une souche dermotrope de Leishmania infantum chez un sidéen. Bull Soc Pathol Exot 1991;84:365-7.
26. Burke E. Abdominal pain in the diagnosis of early kala-azar. Trans R Soc Trop Med Hyg 1944;37:441-5.
27. Veress B, Malik MOA, Satir AA, El Hassan AM. Morphological observations on visceral leishmaniasis in the Sudan. Trop Geogr Med 1974;26:198-203.
28. Sati MH. Leishmanial enteritis as a cause of intractable diarrhoea and death. Sudan Med J 1962;1:216-8.
29. Cole ACE. Kala-azar in East Africa. Trans R Soc Trop Med Hyg 1944;37:409-35.
30. Henderson LH. Clinical observations on kala-azar in the Fung Province of the Sudan. Trans R Soc Trop Med Hyg 1937;31:179-90.
31. Banerjee M, Pal A, Ghosh S, Maitra TK. Small intestinal involvement in visceral leishmaniasis. Am J Gastroenterol 1990;85:1433-4.
32. Sen Gupta PC, Sanyal NN, Bhattacharya B, Mathen KK. Avitaminosis in kala-azar: preliminary observations. Ind Med Gaz 1952;87:444-8.
33. Aikat BK, Sahaya S, Pathania AGS, et al. Clinical profile of cases of kala-azar in Bihar. Indian J Med Res 1979;70:563-70.
34. Rosenthal PJ, Chaisson RE, Hadley WK, Leech JH. Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome. Am J Med 1988;84:307-9.
35. Sendino A, Barbado FJ, Mostaza JM, Fernández-Martín J, Larrauri J, Vázquez-Rodríguez JJ. Visceral leishmaniasis with malabsorption syndrome in a patient with acquired immunodeficiency syndrome. Am J Med 1990;89:673-5.
36. Pesce A, Saint-Paul MC, Vinti H, et al. Leishmaniose gastrique chez un malade atteint de syndrome d'immunodéficience acquise [letter]. Presse Med 1990;19: 178.
37. Datry A, Similowski T, Jais P, et al. AIDS-associated leishmaniasis: an unusual gastro-duodenal presentation. Trans R Soc Trop Med Hyg 1990;84:239-40.
38. Betz P, Elsing C, Purrmann J, Frenzel H. Leishmaniose des oberen gastrointestinaltrakts bei einem HIV-positiven patienten. Pathologe 1990;11:97-100
39. Deseldime L, Coppola F, Mazzuco G, Gastric localization of systemic leishmaniasis in a patient with AIDS. Histopathology 1991;19:93-5.
40. Altés J, Salas A, Llompart A, Obrador A. Small intestinal involvement in visceral leishmaniasis. Am J Gastroenterol 1991;86:1283.
41. Rosenthal E, Marty Pesce A. Leishmania in bronchoalveolar lavage [letter]. Ann Intern Med 1991;114:1064-5.
42. Mediavilla García JD, López-Gómez M, Corrales Torres AJ, Ortiz Flores F, Jiménez-Alonso J. Leishmaniasis esófago-gástrica en un enfermo con infecciön por VIH. Rev Clin Esp 1992;191:335-6.
43. Coppola F, Recchia S, Ferrari A, Del Sedime L. Visceral leishmaniasis in AIDS with gastric involvement. Gastrointest Endosc 1992;38:76-8.
44. Roig P, Cuadrado JM, Benéitez C, et al. Leishmaniasis visceral de localization intestinal en pacientes con infección por el virus de la inmunodeficiencia humana: presentación de dos casos. Rev Clin Esp 1993;192:271-3.
45. Hamour AA, Skelly R, Wilkins EGL, Mandai BK. Visceral leishmaniasis (kala-azar) in two patients with HIV-1 infection. atypical features and response to therapy. In: Proceedings and abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy; 1995; San Francisco (CA). Washington (DC): American Society for Microbiology, 1995:220.
46. Gutiérrez-Macías A, Alonso-Alonso JJ, Aguirre-Errasti C. Esophageal lelishmaniasis in a patient infected with the human inmunodeficiency virus. Clin Infect Dis 1995;21: 229-30.
47. Potter DA, Danforth DN, Macker AM et al. Evaluation of abdominal pain in the AIDS patient. Ann Surg 1984;199: 332-9.
48. Sievert W, Merrel RC Gastrointestinal emergencies in the AIDS patient. Gastroenterol Clin North Am 1988;17:409-18.
49. Macho JR. Gastrointestinal surgery in the AIDS patient. Gastroenterol Clin North Am 1988;17:563-7.
50. Mebrahtu YB, Hendricks LD, Oster CN, et al. Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis in Kenya Am J Trop Med Hyg 1993;48:530-5.
51. Martínez P, de la Vega E, Laguna F, et al. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 1993;7:227-30.
52. Piarroux R, Gambarelli F, Ravaud I, Pizot-Martin I, Toga I, Dumon H. Diagnosis and survey of visceral leishmaniasis in AIDS patients using microscopic examination, culture and PCR amplification on blood samples. In: Proceeding and abstracts of the 5th European Conference on Clinical Aspects and Treatment of HIV infection; 1995; Copenhagen, Denmark:1995:12.
53. Górgolas M, Castrillo JM, Fernández Guerrero ML. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-γ. Clin Infect Dis 1993;17:56-8.
54. Croft SL, Davidson RN, Thornton EA. Liposomal amphotericin B in the treatment of visceral leishmaniasis. J Antimicrob Chemother 1991;28 Suppl B:111-8.
55. Davidson RN, Croft SI, Scott AG, et al. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 1991;337:1061-2.
56. Torre-Cisneros J, Villanueva JL. Efficacy of liposomal anphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus. Clin Infect Dis 1995,20:191.
57. Davidson RN, Di Martino L, Gradoni L, et al. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med 1994,87:75-81.
58. McBride M, Linney M, Claydon EJ, Weber J. Visceral leishmaniasis following treatment with liposomal amphotericin B. Clin Infect Dis 1994;19:362